US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CytoDyn Inc.

0.3030

+0.00290.97%

Volume:1.78M

Turnover:537.13K

Market Cap:415.03M

PE:-7.95

High:0.3130

Open:0.3050

Low:0.2900

Close:0.3001

52wk High:0.3970

52wk Low:0.2050

Shares:1.37B

Float Shares:1.37B

Volume Ratio:0.75

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0381

EPS(LYR):-0.2868

ROE:1659.17%

ROA:-67.45%

PB:-3.98

PE(LYR):-1.06

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CytoDyn Inc.

Exchange:

OTCQB

Establishment Date:

2002

Employees:

13

Office Location:

1111 Main Street,Suite 660,Vancouver,Washington,United States

Website:

http://www.cytodyn.com

Zip Code:

98660

Phone:

Fax:

360 799 5954

Introduction:

CytoDyn Inc., a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CYDY/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CYDY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYDY\",,,,,undefined,":{"symbol":"CYDY","market":"US","secType":"STK","nameCN":"CytoDyn Inc.","latestPrice":0.303,"timestamp":1780084800000,"preClose":0.3001,"halted":0,"volume":1775651,"delay":15,"changeRate":0.00966344551816066,"floatShares":1369571229,"shares":1369733680,"eps":-0.03809,"marketStatus":"Market Closed","change":0.0029,"latestTime":"05-29 16:00:00 EDT Delay","open":0.305,"high":0.313,"low":0.29,"amount":537125.7499800003,"amplitude":0.076641,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.03809,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.3001,"volumeRatio":0.7530519442081669},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYDY\",,,,,undefined,":{"symbol":"CYDY","floatShares":1369571229,"roa":"-67.45%","roe":"1659.17%","lyrEps":-0.286757,"volumeRatio":0.7530519442081669,"shares":1369733680,"dividePrice":0,"high":0.313,"amplitude":0.076641,"preClose":0.3001,"low":0.29,"week52Low":0.205,"pbRate":"-3.98","week52High":0.397,"institutionHeld":0,"latestPrice":0.303,"eps":-0.03809,"divideRate":0,"volume":1775651,"delay":15,"ttmEps":-0.03809,"open":0.305,"prevYearClose":0.28,"prevWeekClose":0.339,"prevMonthClose":0.3097,"prevQuarterClose":0.274,"fiveDayClose":0.3485,"twentyDayClose":0.3097,"sixtyDayClose":0.242},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CYDY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-01-14","symbol":"CYDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736830800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-10-15","symbol":"CYDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1728964800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-08-15","symbol":"CYDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723694400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-04-15","symbol":"CYDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713153600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-01-16","symbol":"CYDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1705381200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CYDY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CYDY\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":10039157,"yearFounded":2002,"employeeNum":13,"address":"1111 Main Street,Suite 660,Vancouver,Washington,United States","zipCode":"98660","officePhone":"360 980 8524","officeFax":"360 799 5954","fiscalYearEnd":"05-31"},"stockCompanyDetail":{"websiteUrl":"http://www.cytodyn.com","stockEarnings":[{"period":"1week","weight":-0.0877},{"period":"1month","weight":-0.1015},{"period":"3month","weight":-0.2113},{"period":"6month","weight":-0.2113},{"period":"1year","weight":-0.3469},{"period":"ytd","weight":-0.2449}],"description":"CytoDyn Inc., a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.","exchange":"OTCQB","name":"CytoDyn Inc.","nameEN":"CytoDyn Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CYDY\",market:\"US\",,,undefined,":null}}